Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASC22 and Chidamide for HIV Functional Cure
NCT05129189Phase 2Unknown
- Start
- Jun 2022
- Primary completion
- Jul 2023
- Modality
- Nanobodies (VHH), Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of envafolimab in human immunodeficiency virus infection (HIV). Status: unknown.
02
Drugs
envafolimab
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT05129189.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05129189.